Abbott Laboratories (ABT) EBITDA Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Abbott Laboratories (ABT) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.43 Bn | 177.83 Bn | 7.27 Bn | -497.00 |
| 2 | Intuitive Surgical | 124.55 Bn | 119.33 Bn | 1.96 Bn | 314.00 |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn | 124.00 |
| 4 | Stryker | 105.51 Bn | 102.03 Bn | 4.50 Bn | 670.00 |
| 5 | Boston Scientific | 66.23 Bn | 65.69 Bn | 3.85 Bn | 546.00 |
| 6 | Edwards Lifesciences | 49.46 Bn | 45.21 Bn | 1.35 Bn | 264.00 |
| 7 | Alcon | 33.87 Bn | 32.41 Bn | 1.68 Bn | -919.00 |
| 8 | Dexcom | 32.08 Bn | 30.13 Bn | 830.00 Mn | 595.00 |
| 9 | Steris | 21.05 Bn | 20.56 Bn | 684.20 Mn | 146.00 |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 54.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -497.00 |
| Mar 31, 2026 | -430.00 |
| Dec 31, 2025 | 223.00 |
| Sep 30, 2025 | 61.00 |
| Jun 30, 2025 | 233.00 |
| Mar 31, 2025 | 243.00 |
| Dec 31, 2024 | 3.00 |
| Sep 30, 2024 | 124.00 |
| Jun 30, 2024 | 63.00 |
| Mar 31, 2024 | -157.00 |
| Dec 31, 2023 | 446.00 |
| Sep 30, 2023 | -77.00 |
| Jun 30, 2023 | -565.00 |
| Mar 31, 2023 | -900.00 |
| Dec 31, 2022 | -781.00 |
| Sep 30, 2022 | -630.00 |
| Jun 30, 2022 | 749.00 |
| Mar 31, 2022 | 431.00 |
| Dec 31, 2021 | -199.00 |
| Sep 30, 2021 | 641.00 |